{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "9793319", "DateCompleted": {"Year": "1999", "Month": "01", "Day": "12"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "18"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1019-5297", "JournalIssue": {"Issue": "5", "PubDate": {"Year": "1998", "Season": "Jul-Aug"}}, "Title": "Likars'ka sprava", "ISOAbbreviation": "Lik Sprava"}, "ArticleTitle": "[Ozone hemotherapy and disorders of the functional energy competence of the cell membranes in gestoses].", "Pagination": {"StartPage": "96", "EndPage": "98", "MedlinePgn": "96-8"}, "Abstract": {"AbstractText": ["A study made on biochemical mechanisms of metabolic abnormalities in grave forms of gestosis should allow some judgement about gravity of pathophysiological alterations developing in the patients' organism, efficiency of intensive therapy, and also attest to the need for instituting some additional corrective measures. Measured in the study were the principle indices for bodily metabolic homeostasis (LPO intensity, AOD, thiol metabolism) in physiological pregnancy and labor as well as in grave forms of gestoses (preeclampsia, gestational hypertension, eclampsia). The obtained results indicated that it is necessary that a specific correction of intracellular metabolism should be carried out in order that possible complications might be prevented. Ozonohemotherapy makes for reduction of oxidated forms of glutathione in red cells and also affects in patients bodily content of thiols and AOD."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Ivanchenko", "ForeName": "S A", "Initials": "SA"}], "PublicationTypeList": ["Comparative Study", "English Abstract", "Journal Article"], "VernacularTitle": "Ozonogemoterapiia i narusheniia funktsional'no-\u00e9nergetichesko\u012d sostoiatel'nosti kletochnykh membran pri gestozakh."}, "MedlineJournalInfo": {"Country": "Ukraine", "MedlineTA": "Lik Sprava", "NlmUniqueID": "9601540", "ISSNLinking": "1019-5297"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Sulfhydryl Compounds"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Blood"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": ["drug effects"], "DescriptorName": "Energy Metabolism"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Erythrocyte Membrane"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": ["blood"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["blood", "therapy"], "DescriptorName": "Pre-Eclampsia"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}, {"QualifierName": [], "DescriptorName": "Pregnancy Trimester, Third"}, {"QualifierName": ["blood"], "DescriptorName": "Sulfhydryl Compounds"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "10", "Day": "30"}, {"Year": "1998", "Month": "10", "Day": "30", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "10", "Day": "30", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9793319"]}}], "PubmedBookArticle": []}